Burundi

in page functions
Total population (2013) 10,162,532
Birth cohort (2013) 454,923
Surviving Infants (surviving to 1 year per year, 2013) 415,682
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 67/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 104/1000
World Bank Index, IDA (2012) 3.08
Gross Nation Income (per capita US$, 2012) 240
Co-financing status (2013) Low-income
No. of districts/territories (2012) 45

GAVI support for Burundi

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Civil Society Organisation support (CSO) $461,520 $461,520 $494,529 107%
Health system strengthening (HSS) $18,797,394 $20,334,663 $17,065,308 91%
HepB mono (NVS) $460,000 $460,000 $460,000 100%
Immunisation services support (ISS) $3,669,980 $3,669,980 $3,435,000 94%
Injection safety support (INS) $390,294 $390,294 $390,294 100%
Measles (NVS) $247,717 $400,217 $245,805 99%
Penta (NVS) $30,651,186 $32,784,186 $29,795,905 97%
Pneumo (NVS) $22,946,560 $22,946,560 $22,532,238 98%
Rotavirus (NVS) $2,135,656 $3,792,656 $1,192,842 56%
Tetra DTP-Hib (NVS) $4,727,594 $4,727,594 $4,727,594 100%
Vaccine Introduction Grant $884,000 $884,000 $884,000 100%
Total $85,371,900 $90,851,669 $81,223,513

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burundi DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
96%

*
DTP3 - Official country estimates (2012) 96%
M:F sex ratio at birth (2013) 1.03
Household survey: DTP3 coverage for male (2011) 95.50%
Household survey: DTP3 coverage for female (2011) 95.20%
Household survey: Last DTP3 survey (2011) 95%
% districts achieving > 80% DTP3 coverage (2012) 93%
% districts achieving < 50% DTP3 coverage (2012) 0%
MCV WHO/UNICEF estimates (2012) 93%
Polio WHO/UNICEF estimates (2012) 94%

Breakdown of support

Non-vaccine support Vaccine support
27% 73%
$22,269,130 $58,954,381

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burundi

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

16 December 2013

Burundi launches a new vaccine against rotavirus diarrhoea

Burundi became on December 16, 2013 the 19th GAVI eligible country to introduce in its routine immunisation programme antirotavirus vaccine. Rotavirus is the leading cause of severe and often fatal diarrhoea among under five children. In Burundi, diarrhoea causes approximately 15 percent of deaths in children less than five years of age. By 2015, GAVI with the support of its donors and partners plan to support the introduction of this vaccine in more than 30 countries.

07 November 2013

Germany statement

GAVI Alliance welcomes Germany’s continued commitment to immunisation

German support set to benefit East African Community and help improve supply chain.

close icon

modal window here